![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » FDA APPROVES GLENMARK'S GENERIC GABAPENTIN
FDA APPROVES GLENMARK'S GENERIC GABAPENTIN
Glenmark Pharmaceuticals has received FDA approval to market gabapentin oral tablets in 600- and 800-mg dosage strengths.
Gabapentin is an anti-convulsant that is prescribed to help control epileptic seizures. It is also widely used to relieve different kinds of pain and even psychiatric disorders.
The drug is a generic version of Pfizer's Neurontin. With this approval, Glenmark will have 10 generics on the market.
KEYWORDS Drug Pipeline Alert
Upcoming Events
-
21Oct